IL6 and COVID-19: As seen with the use of IL-6 targeting in COVID-19, the efficacy of any IL-6 therapy would depend on the severity of the disease and the timing of the intervention; as well as the ability to distinguish between IL-6 as a cause or a consequence of the disease.